维普中文期刊产品整合服务
65篇 您的检索式:作者名="Demediuk"
    题名 作者 年代 出处 被引量
1Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience显示文摘AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting.METHODS We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients receiving a minimum 3 mo tenofovir therapy through St Vincent's Hospital Melbourne, Australia. We included patients receiving tenofovir [tenofovir disoproxil fumarate(TDF)] monotherapy, as well as patients treated with TDF in combination with a second antiviral agent. Patients were excluded if they demonstrated human immune-deficiency virus/hepatitis C virus/hepatitis delta virus coinfection or were less than 18 years of age. We considered virological and biochemicalresponse, as well as safety outcomes. Virological response was determined by measurement of hepatitis B virus(HBV) DNA using sensitive assays; biochemical response was determined via serum liver function tests; histological response was determined from liver biopsy and fibroscan; safety analysis focused on glomerular renal function and bone mineral density. The primary efficacy endpoint was complete virological suppression over time, defined by HBV DNA < 20 IU/m L. Secondary efficacy endpoints included rates of biochemical response, and HB e antigen(HBe Ag)/HB surface antigen loss and seroconversion over time.RESULTS Ninety-two patients were identified who fulfilled the enrolment criteria. Median follow-up was 26 mo(range 3-114). Mean age was 46(24-78) years, 64(70%) were male and 77(84%) were of Asian origin. 55(60%) patients were treatment-na?ve and 62 patients(67%) were HBe Ag-negative. Complete virological suppression was achieved by 45/65(71%) patients at 12 mo, 37/46(80%) at 24 mo and 25/28(89%) at 36 mo. Partial virological response(HBV DNA 20-2000 IU/m L) was achieved by 89/92(96.7%) of patients. Multivariate analysis showed a significant relationship between virological suppression at end of follow-up and baseline HBV DNA level(OR = 0.897, 95%CI: 0.833-0.967, P = 0.0046) and HBe Ag positive status(OR = 0.373, 95%CI: 0.183-0.762, P = 0.0069). There was no difference in response comparing treatment-na?ve and treatment-experienced patients. Three episodes of virological breakthrough occurred in the setting of noncompliance. Tenofovir therapy was well tolerated.CONCLUSION Tenofovir is an efficacious, safe and well-tolerated treatment in an Australian real-world tertiary care setting. Our data are similar to the reported experience from registration trials.Grace C Lovett Tin Nguyen David M Iser Jacinta A Holmes Robert Chen Barbara Demediuk Gideon Shaw Sally J Bell Paul V Desmond Alexander J Thompson 2017World Journal of Hepatology2017,9,1:7
2Decline in intra- cellular free MgZ+is associated with irreversible tissue in- jury after brain trauma 显示文摘Vink R Mcintosh T K Demediuk 1988Journal of Biological Chemis- try1988,263,2:1
3The role of excitatory amino acids and NMDA receptors in traumatic brain injury 显示文摘Faden AI Demediuk P Panter SS Vink R 1989Science1989,244,4906:1
4Lipid hydrolysis and peroxidation in injured spinal cord:partial protection with methylprednisolone or vitamin E and selenium显示文摘Anderson DK Saunders RD Demediuk P 1985Cent Nerv Syst Trauma1985,2,4:1
5The role of excitatory amino acids and NMDA recept'ors in traumatic head injury显示文摘Faden AI Demediuk P Panter SS 1989Science1989,244,:1
6Decline in intracellular free Mg^2+ is associated with irreversidle tissue injury after brain trauma 显示文摘Vink R Mclntosh TK Demediuk P 2008JBiolChem2008,263,:1
7Traumatic spinal cord injury in rabbits decreases intracellular free magnesium concentration as measured by 31p MRS显示文摘Vink R Yum SW Demediuk P 0,,01:1
8Effects of methl-prednisolone and the combination of alpha-tocopherol and se-lenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue显示文摘Saunders RD Dugan LL Demediuk P 1987J Neurochem1987,49,1:1
9Decline in intracellular fee Mg^2+ is associated with irreversible tissue injury after brain traum显示文摘Vink R McIntosh TK Demediuk P 1988Bid Chem1988,263,2:1
10Decline in intracellular free Mg^2+ is associated with irreversible tissue injury after brain trauma 显示文摘Vink R McIntosh TK Demediuk P 1988J Biol Chem1988,263,:1
11The role of ecitatory amino acids and NMDA receotors in traumatic head injury显示文摘 Demediuk P Panter SS 1989Science1989,244,:1
12Effects of methylprednisolone and the combination of alpha-gocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue显示文摘Sauaders RD Dugan LL Demediuk P 1987J Neurochem1987,49,:1
13Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue 显示文摘Saunders RD Dugan LL Demediuk P 1987J Neurochem1987,49,1:1
14Study of magnesium oxy-sul- phates 显示文摘Demediuk T Cole W F A 1957Australian J Chem1957,10,2:1
15Lipid hydrolysis and peroxidation in injured spinal cord:partial protection with methylprednisolone or vitamin E and slenium 显示文摘Anderson DK Saunders RD Demediuk P 1985Cent Nerv Syst Trauma1985,2,4:1
16A GC-rich element confers epidermal growth factor responsiveness to transcription from the gastrin promoter显示文摘Merchant JL Demediuk B Brand SJ 1991Mol Cell Biol1991,11,:1
17Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue显示文摘Saunders RD Dugan LL Demediuk P 1987J Neurochem1987,49,1:1
18Studies on magnesium and calcium oxychlorides显示文摘Demediuk T Cole W Hueber H 1955Australian Journal of Chemistry1955,8,2:1
19Decrease in total and free magnesium concentration following traumatic brain injury in rats显示文摘Vink R Mclntosh JK Demediuk P 1987Biochem Biophys Res Commun1987,149,:1
20A GC-rich element confers epidermal growth factor responsiveness to transcription from the gastrin promoter显示文摘 Demediuk B Brand SJ 1991Mol Cell Biol1991,1,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费